T9G — Vidac Pharma Holding Balance Sheet
0.000.00%
- €26.73m
- €27.36m
Annual balance sheet for Vidac Pharma Holding, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Short Term Investments | 0.123 | 0.034 | 0.06 | 0.44 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 0.037 | 0.008 | 0.054 | 0.024 |
Prepaid Expenses | ||||
Total Current Assets | 0.16 | 0.042 | 0.116 | 0.464 |
Net Property, Plant And Equipment | 0.005 | 0.005 | 0.003 | 0.003 |
Other Long Term Assets | ||||
Total Assets | 0.172 | 0.047 | 0.119 | 0.467 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Current Liabilities | 0.283 | 0.795 | 0.875 | 1.12 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Liabilities | 0.283 | 0.795 | 0.875 | 1.12 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | -0.111 | -0.748 | -0.756 | -0.65 |
Total Liabilities & Shareholders' Equity | 0.172 | 0.047 | 0.119 | 0.467 |
Total Common Shares Outstanding |